- Point-of-care (POC) diagnostics, enabling rapid medical testing at or near the site of patient care, are becoming crucial in the Middle East and Africa due to their ability to deliver timely results without the need for centralized laboratories, improving clinical decision-making and patient management in both urban and remote healthcare settings
- The growing demand for POC diagnostics is primarily fueled by the high prevalence of infectious diseases such as HIV, malaria, and tuberculosis, along with a rising need for chronic disease monitoring and increasing awareness around early disease detection
- Saudi Arabia dominated the Middle East and Africa point-of-care diagnostics market with the largest revenue share of 29.1% in 2024, supported by expanding healthcare infrastructure, government-led digital health initiatives under Vision 2030, and strategic investments to enhance diagnostic accessibility and quality
- Nigeria is expected to be the fastest growing country in the Middle East and Africa point-of-care diagnostics market during the forecast period, due to increasing international funding, improved supply chains, and the urgent need for rapid diagnostics to manage communicable and non-communicable diseases in underserved populations
- Infectious disease testing segment dominated the Middle East and Africa point-of-care diagnostics market with a market share of 47.8% in 2024, driven by targeted efforts to control epidemics and the need for fast, reliable testing in both clinical and community health environments
